TerminatedPhase 2NCT05710640
Transcutaneous Cervical Vagus Nerve Stimulation (tcVNS) in JIA
Studying Juvenile idiopathic arthritis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Principal Investigator
- Beth Gottlieb, MD, MDFeinstein Institutes for Medical Research, Cohen Children's Medical Center: Pediatric Rheumatology
- Intervention
- Active tcVNS(device)
- Enrollment
- 18 enrolled
- Eligibility
- 5-18 years · All sexes
- Timeline
- 2023 – 2025
Study locations (7)
- University of California San Francisco School of Medicine: Department of Pediatrics, Division of Pediatric Rheumatology, San Francisco, California, United States
- Nemours Children's Health: Department of Pediatric Rheumatology, Orlando, Florida, United States
- Indiana University Medical Center: Riley Hospital for Children Department of Pediatric Rheumatology, Indianapolis, Indiana, United States
- Feinstein Institutes for Medical Research, Cohen Children's Medical Center: Pediatric Rheumatology, Lake Success, New York, United States
- Stephen D. Hassenfield Children's Center at NYU Langone Health, New York, New York, United States
- Division of Pediatric Rheumatology at the University of Utah School of Medicine and Primary Children's Hospital, Salt Lake City, Utah, United States
- Seattle Children's Hospital: Rheumatology Clinic, Seattle, Washington, United States
Collaborators
Autoimmunity Centers of Excellence (ACE) · Northwell Health
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05710640 on ClinicalTrials.govOther trials for Juvenile idiopathic arthritis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07553182OLE Study With Filgotinib in JIAAlfasigma S.p.A.
- ENROLLING BY INVITATIONPHASE3NCT07386587Methotrexate Alone vs Methotrexate + Etanercept for Minimal/Low Disease Activity in Juvenile Idiopathic ArthritisUniversity of Child Health Sciences and Children's Hospital, Lahore
- RECRUITINGPHASE3NCT06654882Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic ArthritisDuke University
- RECRUITINGNCT07243782Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cosentyx®(Secukinumab) in KoreaNovartis Pharmaceuticals
- RECRUITINGNANCT07217782Pain in Juvenile ArthritisWashington University School of Medicine
- RECRUITINGNCT07185750Investigation of Catastrophizing of Pain Reported by Parents in JIA PatientsHacettepe University
- RECRUITINGNCT06718569Pain in Inflammatory Joint DiseasesDiakonhjemmet Hospital
- RECRUITINGNCT06806774Reliability and Validity of the Glittre Activities of Daily Living Test in Children and Adolescents With Juvenile Idiopathic ArthritisHacettepe University